What was Oncimmune Holdings PLC’s price range in the past 12 months?
Oncimmune Holdings PLC lowest share price was 9.75p and its highest was 31.00p in the past 12 months.
What is Oncimmune Holdings PLC’s market cap?
Currently, no data Available
When is Oncimmune Holdings PLC’s upcoming earnings report date?
Oncimmune Holdings PLC’s upcoming earnings report date is Feb 27, 2025 which is in 235 days.
How were Oncimmune Holdings PLC’s earnings last quarter?
Oncimmune Holdings PLC released its earnings results on May 21, 2024. The company reported 0.11p earnings per share for the quarter, beating the consensus estimate of N/A by 0.11p.
Oncimmune Holdings PLC does not currently pay dividends.
What is Oncimmune Holdings PLC’s EPS estimate?
Oncimmune Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncimmune Holdings PLC have?
Oncimmune Holdings PLC has 74,142,140 shares outstanding.
What happened to Oncimmune Holdings PLC’s price movement after its last earnings report?
Oncimmune Holdings PLC reported an EPS of 0.11p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.811%.
Which hedge fund is a major shareholder of Oncimmune Holdings PLC?
Currently, no hedge funds are holding shares in GB:ONC
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes EarlyCDT and ImmunoINSIGHTS. It generates maximum revenue from the EarlyCDT segment.